Childhood interstitial lung diseases in immunocompetent children in Australia and New Zealand: a decade’s experience
Abstract Background Childhood interstitial lung disease (chILD) represents a rare heterogeneous group of respiratory disorders. In the absence of randomized controlled clinical trials, global collaborations have utilized case series with an aim to standardising approaches to diagnosis and management...
Main Authors: | Vishal Saddi, Sean Beggs, Bruce Bennetts, Joanne Harrison, Neil Hime, Nitin Kapur, Jill Lipsett, Lawrence M. Nogee, Amy Phu, Sadasivam Suresh, André Schultz, Hiran Selvadurai, Stephanie Sherrard, Roxanne Strachan, Julian Vyas, Yvonne Zurynski, Adam Jaffé |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2017-07-01
|
Series: | Orphanet Journal of Rare Diseases |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s13023-017-0637-x |
Similar Items
-
Prospective evaluation of hydroxychloroquine in pediatric interstitial lung diseases: Study protocol for an investigator-initiated, randomized controlled, parallel-group clinical trial
by: Matthias Griese, et al.
Published: (2020-04-01) -
Childhood interstitial lung disease: When to suspect and what to do
by: Grazia Fenu, et al.
Published: (2024-06-01) -
Randomized controlled phase 2 trial of hydroxychloroquine in childhood interstitial lung disease
by: Matthias Griese, et al.
Published: (2022-07-01) -
Hydroxychloroquine, a successful treatment for lung disease in ABCA3 deficiency gene mutation: a case report
by: Waleed Shaaban, et al.
Published: (2021-02-01) -
A Rare Pediatric Case of Severe Bird Fancier’s Lung Presented with Viral Pneumonitis-Like Picture
by: Basel Habra, et al.
Published: (2018-11-01)